# Monitored Anesthesia Care: Dexmedetomidine-Ketamine Versus Dexmedetomidine- Propofol For Chronic Subdural Hematoma

> **NCT04621526** · PHASE1,PHASE2 · COMPLETED · sponsor: **Zagazig University** · enrollment: 56 (actual)

## Conditions studied

- Conscious Sedation

## Interventions

- **DRUG:** dexmedetomidine- ketamine
- **DRUG:** dexmedetomidine- propofol

## Key facts

- **NCT ID:** NCT04621526
- **Lead sponsor:** Zagazig University
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-10
- **Primary completion:** 2023-08-30
- **Final completion:** 2023-08-30
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2023-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04621526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04621526, "Monitored Anesthesia Care: Dexmedetomidine-Ketamine Versus Dexmedetomidine- Propofol For Chronic Subdural Hematoma". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT04621526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*